Validation of the Multiple Sclerosis International Quality of Life questionnaire

Multiple Sclerosis

Volumn 14, Issue 2, 2008, Pages 219-230

  Simeoni, M C ^a   Auquier, Pascal ^b   Fernandez, O ^b   Flachenecker, P ^c,d   Stecchi, S ^e   Constantinescu, C S ^f   Idiman, E ^g   Boyko, A ^h   Beiske, A G ⁱ   Vollmer, T ^j   Triantafyllou, N ^k   O'Connor, P ^l   Barak, Y ^m   Biermann, L ⁿ   Cristiano, E ^o   Atweh, S ^p   Patrick, D L ^q   Robitail, S ^a   Ammoury, N ^r   Beresniak, A ^s   Pelletier, J ^a   more..

^a TIMONE HOSPITAL   (France)

^b HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d Neurological Rehabilitation Center Quellenhof   (Germany)

^e Centro SM   (Italy)

^f NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^g DOKUZ EYLUL UNIVERSITY   (Turkey)

^h PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

ⁱ AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^j BARROW NEUROLOGICAL INSTITUTE   (United States)

^k NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^l ST MICHAEL'S HOSPITAL   (Canada)

^m TEL AVIV UNIVERSITY   (Israel)

ⁿ Department of Neurology University of Buenos Aires Head Neurology Hospital Italiano de Buenos Aires ^*  (South Africa)

^o UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^p AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^q UNIVERSITY OF WASHINGTON   (United States)

^r Serono International SA   (Switzerland)

^s UNIVERSITÉ PARIS DESCARTES   (France)

more..

Author keywords

international; multiple sclerosis; MusiQoL; quality of life; questionnaire; validation

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; CORRELATION ANALYSIS; DAILY LIFE ACTIVITY; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HEALTH CARE QUALITY; HEALTH STATUS; HUMAN; INTERNAL CONSISTENCY; INTERNAL VALIDITY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS INTERNATIONAL QUALITY OF LIFE QUESTIONNAIRE; OUTCOME ASSESSMENT; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; REPRODUCIBILITY; SHORT FORM 36; SOCIAL STATUS; VALIDITY;

FEMALE; HEALTH STATUS; HUMANS; MALE; MULTIPLE SCLEROSIS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; WORLD HEALTH;

EID: 43149122517     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458507080733     Document Type: Article

References (71)

1. Spilker B. Quality of life and pharmacoeconomics in clinical trials, second edition. Philadelphia: Lippincott-Raven, 1996: 1-11.
2. Ganz PA Impact of quality of life outcomes on clinical practice. Oncology 1995; 9 (suppl 11): 61-5.
3. Solari A. Role of health-related quality of life measures in the routine care of people with multiple sclerosis. Health Qual Life Outcomes 2005; 3 (1): 16.
4. Leplege A., Hunt S. The problem of quality of life in medicine. JAMA 1997; 278 (1): 47-50.
5. McKenna SP Measuring quality of life in schizophrenia. Eur Psychiatry 1997; 12 (Suppl 3): S267-74.
6. Gruenewald DA, Higginson IJ, Vivat B., Edmonds P., Burman RE Quality of life measures for the palliative care of people severely affected by multiple sclerosis: a systematic review. Mult Scler 2004; 10 (6): 690-704.
7. Mitchell AJ, Benito-Leon J., Gonzalez JM, Rivera-Navarro J. Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of well-being. Lancet Neurol 2005; 4 (9): 556-66.
8. Poser CM, Paty DW, Scheinberg L., McDonald WI, Davis FA, Ebers GC et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
9. McDonald WI, Compston A., Edan G., Goodkin D., Hartung HP, Lublin FD et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 122-7.
10. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30 (6): 473-83.
11. Kurtzke JF Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
12. Kurtzke JF On the evaluation of disability in multiple sclerosis. Neurology 1961; 11: 686-94.
13. Hauser SL, Dawson DM, Lehrich JR, Beal MF, Kevy SV, Propper RD et al. Intensive immunosuppression in progressive multiple sclerosis. N Engl J Med 1983; 308: 173-8.
14. Folstein MF, Robins LN, Helzer JE The mini-mental state examination. Arch Gen Psychiatry 1983; 40 (7): 812.
15. Guy W. ECDEU Assessment manual for psychopharmacology, revised. MD: Rockville, U.S. Department of Health and Human Services, 1976: 218-22.
16. Juniper EF, Guyatt GH, Jaeschke R. How to develop and validate a new health related quality of life instruments. In Spilker B ed. Quality of life and pharmacoeconomics in clinical trials, second edition. Philadelphia: Lippincott-Raven, 1996: 49-56.
17. Pascoe G. Patient satisfaction in primary health care. A literature review and analysis. Eval Prog Planning 1983; 6: 185-210.
18. Calman M. Towards a conceptual framework of lay evaluation of health care. Soc Sci Med 1988; 27: 927-33.
19. Guillemin F., Bombardier C., Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993; 46 (12): 1417-32.
20. Nunnally JC, Bernstein ICH. Statistical Foundations. Psychometric theory, third edition. New York: Mc Graw-Hill, 1994: 31-208.
21. Campbell DT, Fiske DW Convergent and discriminant validation by the multi-trait multi-method matrix. Psychol Bull 1959; 56: 85-105.
22. Cronbach LJ Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297-334.
23. Wright BD, Stone MH Best test design: Rasch measurement. Chicago: MESA Press, 1979.
24. Tabachnik BG, Fidell LS Using multivariate statistics, fourth edition. Needham Heights, MA: Allyn and Bacon, Boston, 2001.
25. Adamantios D., Judy AS Introducing LISREL. London: Sage Publications, 2001.
26. March HW, Balla JR, Mc Donald RP Goodness of fit indexes in confirmatory factor analysis: the effect of sample size. Psychol Bull 1998; 103 (3): 391-410.
27. Hu L., Bentler PM Evaluating model fit. In Hoyle RH, ed. Structural equation modeling: concepts, issues, and applications. Thousand Oaks, CA: Sage, 1995: 76-99.
28. Fisher WP Jr. Physical disability construct convergence across instruments: towards a universal metric. J Outcome Meas 1997; 1: 87-113.
29. Keenan A-M., Redmond AC, Horton M., Conaghan PG, Tennant A. The Foot Posture Index: Rasch analysis of a novel, foot-specific outcome measure. Arch Phys Med Rehabil 2007; 88: 88-93.
30. Samsa G., Edelman D., Rothman ML, Williams GR, Lipscomb J., Matchar D. Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics 1999; 15 (2): 141-55.
31. Schwid SR, Goodman AD, McDermott MP, Bever CF, Cook SD Quantitative functional measures in MS: what is a reliable change? Neurology 2002; 58 (8): 1294-6.
32. Ware JE, Harris WJ, Gandek B., Rogers BW, Reese PR MAP-R for Windows: multitrait/multi-item analysis program-revised user's guide. Boston, MA: Health Assessment Lab, 1997.
33. Lisrel software. LISREL 8.51. Chicago, IL: Scientific Software International, 2001.
34. Linacre MJ, Wright BD A user's guide to WinSteps, Rasch-model computer programs. Chicago: MESA Press, 1998.
35. Greenhalgh J., Ford H., Long AF, Hurst K. The MS Symptom and Impact Diary (MSSID): psychometric evaluation of a new instrument to measure the day to day impact of multiple sclerosis. J Neurol Neurosurg Psychiatry 2004; 75 (4): 577-82.
36. Fischer JS, LaRocca NG, Miller DM, Ritvo PG, Andrews H., Paty D. Recent developments in the assessment of quality of life in multiple sclerosis (MS). Mult Scler 1999; 5 (4): 251-9.
37. Freeman JA, Hobart JC, Thompson AJ Does adding MS-specific items to a generic measure (the SF-36) improve measurement. ? Neurology 2001; 57: 68-74.
38. Riazi A., Hobart JC, Lamping DL, Fitzpatrick R., Thompson AJ Evidence-based measurement in multiple sclerosis: the psychometric properties of the physical and psychological dimensions of three quality of life rating scales. Mult Scler 2003; 9: 411-19.
39. Prieto L., Novick D., Sacristan JA, Edgell ET, Alonso J.; SOHO Study Group. A Rasch model analysis to test the cross-cultural validity of the EuroQoL-5D in the Schizophrenia Outpatient Health Outcomes Study. Acta Psychiatr Scand Suppl 2003; 416: 24-9.
40. Robitail S., Ravens-Sieberer U., Simeoni MC, Rajmil L., Bruil J., Power M., et al. Testing the structural and cross-cultural validity of the KIDSCREEN-27 quality of life questionnaire. Qual Life Res 2007; 16 (8): 1335-45.
41. Crane P., Hart D., Gibbons L., Cook K. A 37-item shoulder functional status item pool had negligible differential item functioning. J Clin Epidemiol 2006; 59: 478-84.
42. Erhart M., Ravens-Sieberer U., Hagquist C., Robitail S., van Buuren S. Does correcting for differential item functioning (DIF) using two different techniques enhance the validity and diagnostic quality of adolescents HRQoL test scores? Qual Life Res 2006; 15 (9): A113-A4.
43. Ford HL, Gerry E., Tennant A., Whalley D., Haigh R., Johnson MH Developing a disease-specific quality of life measure for people with multiple sclerosis. Clin Rehabil 2001; 15 (3): 247-58.
44. Hobart J., Lamping D., Fitzpatrick R., Riazi A., Thompson A. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain 2001; 124 (Pt 5): 962-73.
45. Somerset M., Campbell R., Sharp DJ, Peters TJ What do people with MS want and expect from health-care services? Health Expect 2001; 4 (1): 29-37.
46. Nortvedt MW, Riise T., Myhr KM, Landtblom AM, Bakke A., Nyland HI Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction. Mult Scler 2001; 7 (4): 231-5.
47. Schmidt EZ, Hofmann P., Niederwieser G., Kapfhammer HP, Bonelli RM Sexuality in multiple sclerosis. J Neural Transm 2005; 112 (9): 1201-11.
48. Courts NF, Buchanan EM, Werstlein PO Focus groups: the lived experience of participants with multiple sclerosis. J Neurosci Nurs 2004; 36 (1): 42-7.
49. Somerset M., Peters TJ, Sharp DJ, Campbell R. Factors that contribute to quality of life outcomes prioritised by people with multiple sclerosis. Qual Life Res 2003; 12 (1): 21-9.
50. Benito-Leon J., Morales JM, Rivera-Navarro J., Mitchell A. A review about the impact of multiple sclerosis on health-related quality of life. Disabil Rehabil 2003; 25 (23): 1291-303.
51. Ford HL, Gerry E., Tennant A., Whalley D., Haigh R., Johnson MH Developing a disease-specific quality of life measure for people with multiple sclerosis. Clin Rehabil 2001; 15 (3): 247-58.
52. Pittock SJ, Mayr WT, McClelland RL, Jorgensen NW, Weinshenker BG, Noseworthy J. et al. Quality of life is favorable for most patients with multiple sclerosis: a population-based cohort study. Arch Neurol 2004; 61 (5): 679-86.
53. Ozakbas S., Cagiran I., Ormeci B., Idiman E. Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis. J Neurol Sci 2004; 218 (1-2): 3-7.
54. Janssens AC, van Doorn PA, de Boer JB, Kalkers NF, van der Meche FG, Passchier J. et al. Anxiety and depression influence the relation between disability status and quality of life in multiple sclerosis. Mult Scler 2003; 9 (4): 397-403.
55. O'Connor P., Lee L., Ng PT, Narayana P., Wolinsky JS Determinants of overall quality of life in secondary progressive MS: a longitudinal study. Neurology 2001; 57 (5): 889-91.
56. Nortvedt MW, Riise T., Myhr KM, Nyland HI Quality of life in multiple sclerosis: measuring the disease effects more broadly. Neurology 1999; 53 (5): 1098-103.
57. Solari A., Filippini G., Mendozzi L., Ghezzi A., Cifani S., Barbieri E. et al. Validation of Italian multiple sclerosis quality of life 54 questionnaire. J Neurol Neurosurg Psychiatry 1999; 67 (2): 158-62.
58. Hemmett L., Holmes J., Barnes M., Russell N. What drives quality of life in multiple sclerosis? QJM 2004; 97 (10): 671-6.
59. Ford HL, Gerry E., Johnson MH, Tennant A. Health status and quality of life of people with multiple sclerosis. Disabil Rehabil 2001; 23 (12): 516-21.
60. Meyers AR, Gage H., Hendricks A. Health-related quality of life in neurology. Arch Neurol 2000; 57 (8): 1224-7.
61. Nortvedt MW, Riise T. The use of quality of life measures in multiple sclerosis research. Mult Scler 2003; 9 (1): 63-72.
62. Myers JA, McPherson KM, Taylor WJ, Weatherall M., McNaughton HK Duration of condition is unrelated to health-state valuation on the EuroQoL. Clin Rehabil 2003; 17 (2): 209-15.
63. Marrie RA, Miller DM, Chelune GJ, Cohen JA Validity and reliability of the MSQLI in cognitively impaired patients with multiple sclerosis. Mult Scler 2003; 9 (6): 621-6.
64. Auquier P., Simeoni MC, Sapin C., Reine G., Aghababian V., Cramer J. et al. Development and validation of a patient-based health-related quality of life questionnaire in schizophrenia: the S-QoL. Schizophr Res 2003; 63 (1-2): 137-49.
65. Gold SM, Schulz H., Monch A., Schulz KH, Heesen C. Cognitive impairment in multiple sclerosis does not affect reliability and validity of self-report health measures. Mult Scler 2003; 9 (4): 404-10.
66. Lincoln NB, Dent A., Harding J., Weyman N., Nicholl C., Blumhardt LD et al. Evaluation of cognitive assessment and cognitive intervention for people with multiple sclerosis. J Neurol Neurosurg Psychiatry 2002; 72 (1): 93-8.
67. Benito-Leon J., Morales JM, Rivera-Navarro J. Health-related quality of life and its relationship to cognitive and emotional functioning in multiple sclerosis patients. Eur J Neurol 2002; 9 (5): 497-502.
68. Cella DF, Dineen K., Arnason B., Reder A., Webster KA, Karabatsos G. et al. Validation of the functional assessment of multiple sclerosis quality of life instrument. Neurology 1996; 47 (1): 129-39.
69. Vickrey BG, Hays RD, Harooni R., Myers LW, Ellison GW A health-related quality of life measure for multiple sclerosis. Qual Life Res 1995; 4 (3): 187-206.
70. Visschedijk MA, Uitdehaag BM, Klein M., van der Ploeg E., Collette EH, Vluegels L. et al. Value of health-related quality of life to predict disability course in multiple sclerosis. Neurology 2004; 63 (11): 2046-50.
71. Nortvedt MW, Riise T., Myhr KM, Nyland HI Quality of life as a predictor for change in disability in MS. Neurology 2000; 55 (1): 51-4.